Joseph R. Trpik JR - Jan 23, 2023 Form 4 Insider Report for EXELON CORP (EXC)

Role
Senior VP & Corp. Controller
Signature
Elizabeth M. Hensen, Attorney-in-Fact for Joseph Trpik Jr
Stock symbol
EXC
Transactions as of
Jan 23, 2023
Transactions value $
-$359,987
Form type
4
Date filed
1/25/2023, 02:52 PM
Previous filing
Nov 1, 2022
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXC Common Stock Options Exercise +11.2K +41.9% 37.8K Jan 23, 2023 Direct F1
transaction EXC Common Stock Tax liability -$144K -3.44K -9.09% $41.82 34.4K Jan 23, 2023 Direct
transaction EXC Common Stock Disposed to Issuer -$216K -5.17K -15.03% $41.82 29.2K Jan 23, 2023 Direct
holding EXC Common Stock (401k Shares) 1.4K Jan 23, 2023 Direct F11
holding EXC Common Stock 6.27K Jan 23, 2023 Held by spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXC 2023 Restricted Stock Units Award +3.95K 3.95K Jan 23, 2023 Common Stock 3.95K $0.00 Direct F2
transaction EXC 2022 Restricted Stock Units Options Exercise -1.29K -33.33% 2.58K Jan 23, 2023 Common Stock 1.29K $0.00 Direct F3, F4
transaction EXC 2021 Restricted Stock Units Options Exercise -1.32K -50% 1.32K Jan 23, 2023 Common Stock 1.32K $0.00 Direct F3, F5
transaction EXC 2020 Restricted Stock Units Options Exercise -1.26K -100% 0 Jan 23, 2023 Common Stock 1.26K $0.00 Direct F3, F6
transaction EXC Earned Performance RSU Options Exercise -7.3K -100% 0 Jan 23, 2023 Common Stock 7.3K $0.00 Direct F7
holding EXC Restricted Stock Unit Award 10/28/2022 25.2K Jan 23, 2023 Common Stock 25.2K $0.00 Direct F8, F9
holding EXC Deferred Comp Phantom Shares 519 Jan 23, 2023 Common Stock 519 $0.00 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Common shares acquired from vested equity awards granted under the Exelon Long-term Incentive Plan (LTIP).
F2 Restricted stock unit (RSU) award granted under the Exelon LTIP. Award vests in 1/3 increments at the January or February meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock upon vesting. The award accrues quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award.
F3 Vesting of previously granted RSU award under the Exelon LTIP. See footnote #2 for details about the award's terms and vesting schedule.
F4 The RSU award acquired 87 additional shares through automatic dividend reinvestment during the period from May 10, 2022 through December 31, 2022.
F5 The RSU award acquired 60 additional shares through automatic dividend reinvestment during the period from May 10, 2022 through December 31, 2022.
F6 The RSU award acquired 28 additional shares through automatic dividend reinvestment during the period from May 10, 2022 through December 31, 2022.
F7 Vesting of previously granted RSU award under the LTIP. This award cliff vests at the January 2023 meeting of the Exelon Compensation Committee with each RSU representing the right to receive one share of Exelon common stock.
F8 RSU award granted under the LTIP with each RSU representing the right to receive one share of Exelon common stock upon vesting. Shares will vest in 1/3 increments on the first, second and third anniversary of the award date referenced in Column 1. The award accrues quarterly dividend equivalents in the form of additional RSUs representing common stock dividends as approved by the Board, which vest on the same schedule as the underlying RSU award.
F9 The RSU award acquired 204 additional shares during 2022 through automatic dividend reinvestment.
F10 Phantom share equivalents held as of December 31, 2022 in the Exelon stock fund within the Exelon Deferred Compensation Plan, which is multi-fund, non-qualified deferred compensation plan. The share equivalents within the fund will be settled in cash upon the reporting person's separation from the company for any reason. The balance includes 12 additional share equivalents accrued during 2022 through automatic dividend reinvestment.
F11 Balance as of December 31, 2022.